Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06356857

Assessing Repeatability and Intra-individual Variability in [O15]H2O-PET Myocardial Perfusion Imaging

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Peter Hovind · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

This study wish to assess the reproducibility of baseline and hyperemic myocardial blood flow as well as myocardial blood flow reserve measurements with \[O15\]H2O-PET-MPI.

Detailed description

Myocardial perfusion imaging (MPI) using \[O15\]H2O-PET-CT represents a validated technique for quantitatively assessing myocardial blood flow (MBF) and myocardial flow reserve (MFR). With advancements in scanner and software technology, it is now possible to accurately quantify both global and regional MBF in clinical PET-MPI studies. Reduced stress MBF or MFR, as determined by \[O15\]H2O-PET-MPI, is a reliable indicator for detecting hemodynamically significant coronary artery stenosis. Additionally, MBF and MFR offer valuable prognostic insights into mortality and the risk of myocardial infarction. Clinical experience suggests that implementing \[O15\]H2O-PET-MPI for coronary artery disease evaluation is not only feasible but also aids in making informed decisions regarding revascularization. This study wish to assess the reproducibility of baseline and hyperemic myocardial blood flow as well as myocardial blood flow reserve measurements with \[O15\]H2O-PET-MPI.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMyocardial perfusion imaging (MPI) using [O15]H2O-PET-CTRe-scan for comparison with initial scan

Timeline

Start date
2024-04-15
Primary completion
2025-03-17
Completion
2026-03-17
First posted
2024-04-10
Last updated
2025-04-06

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06356857. Inclusion in this directory is not an endorsement.